Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R FRASER

Showing results (871-880 of 891) with videos related to

Pageof 90
Sort By:
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
BMJ Open|November 9, 2021
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)Paul Noel Brennan, Mark MacMillan, Thomas Manship, et al.
Science Translational Medicine|January 17, 2020
Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularizationShareen Forbes, Andrew R Bond, Kayleigh L Thirlwell, et al.
Ecology|January 28, 2017
Circumpolar analysis of the Adélie Penguin reveals the importance of environmental variability in phenological mismatchCasey Youngflesh, Stephanie Jenouvrier, Yun Li, et al.
Stem Cells Translational Medicine|January 29, 2019
Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical TrialJohn D M Campbell, Sajjad Ahmad, Ashish Agrawal, et al.
Nature Medicine|October 9, 2019
Safety profile of autologous macrophage therapy for liver cirrhosisFrancesca Moroni, Benjamin J Dwyer, Catriona Graham, et al.
Leukemia|December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over timeS K Kumar, A Dispenzieri, R Fraser, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Bone Marrow Transplantation|September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysisA Mahindra, P Hari, R Fraser, et al.
Pageof 90

Showing results (871-880 of 891) with videos related to

Sort By:
Pageof 90
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
BMJ Open|November 9, 2021
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)Paul Noel Brennan, Mark MacMillan, Thomas Manship, et al.
Science Translational Medicine|January 17, 2020
Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularizationShareen Forbes, Andrew R Bond, Kayleigh L Thirlwell, et al.
Ecology|January 28, 2017
Circumpolar analysis of the Adélie Penguin reveals the importance of environmental variability in phenological mismatchCasey Youngflesh, Stephanie Jenouvrier, Yun Li, et al.
Stem Cells Translational Medicine|January 29, 2019
Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical TrialJohn D M Campbell, Sajjad Ahmad, Ashish Agrawal, et al.
Nature Medicine|October 9, 2019
Safety profile of autologous macrophage therapy for liver cirrhosisFrancesca Moroni, Benjamin J Dwyer, Catriona Graham, et al.
Leukemia|December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over timeS K Kumar, A Dispenzieri, R Fraser, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Bone Marrow Transplantation|September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysisA Mahindra, P Hari, R Fraser, et al.
Pageof 90